These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


417 related items for PubMed ID: 34313171

  • 1. The Role of Androgen Receptor Splicing Variant 7 in Predicting the Prognosis of Metastatic Castration-Resistant Prostate Cancer: Systematic Review and Meta-Analysis.
    Liu RJ, Hu Q, Li SY, Mao WP, Xu B, Chen M.
    Technol Cancer Res Treat; 2021; 20():15330338211035260. PubMed ID: 34313171
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.
    Antonarakis ES, Lu C, Luber B, Wang H, Chen Y, Nakazawa M, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J.
    JAMA Oncol; 2015 Aug; 1(5):582-91. PubMed ID: 26181238
    [Abstract] [Full Text] [Related]

  • 4. Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Castration-resistant Prostate Cancer with Next generation Androgen Receptor Signal Inhibition: A Systematic Review and Meta-analysis.
    Li H, Wang Z, Tang K, Zhou H, Liu H, Yan L, Guan W, Chen K, Xu H, Ye Z.
    Eur Urol Focus; 2018 Jul; 4(4):529-539. PubMed ID: 28753843
    [Abstract] [Full Text] [Related]

  • 5. Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis.
    Wang J, Zhang Y, Wei C, Gao X, Yuan P, Gan J, Li R, Liu Z, Wang T, Wang S, Liu J, Liu X.
    Front Oncol; 2020 Jul; 10():562504. PubMed ID: 33330031
    [Abstract] [Full Text] [Related]

  • 6. Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer.
    Scher HI, Graf RP, Schreiber NA, McLaughlin B, Lu D, Louw J, Danila DC, Dugan L, Johnson A, Heller G, Fleisher M, Dittamore R.
    Eur Urol; 2017 Jun; 71(6):874-882. PubMed ID: 27979426
    [Abstract] [Full Text] [Related]

  • 7. Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer.
    Scher HI, Lu D, Schreiber NA, Louw J, Graf RP, Vargas HA, Johnson A, Jendrisak A, Bambury R, Danila D, McLaughlin B, Wahl J, Greene SB, Heller G, Marrinucci D, Fleisher M, Dittamore R.
    JAMA Oncol; 2016 Nov 01; 2(11):1441-1449. PubMed ID: 27262168
    [Abstract] [Full Text] [Related]

  • 8. AR-V7 in circulating tumor cells cluster as a predictive biomarker of abiraterone acetate and enzalutamide treatment in castration-resistant prostate cancer patients.
    Okegawa T, Ninomiya N, Masuda K, Nakamura Y, Tambo M, Nutahara K.
    Prostate; 2018 Jun 01; 78(8):576-582. PubMed ID: 29508425
    [Abstract] [Full Text] [Related]

  • 9. Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer.
    Armstrong AJ, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Anand M, Berry WR, Zhang T, Harrison MR, Lu C, Chen Y, Galletti G, Schonhoft JD, Scher HI, Wenstrup R, Tagawa ST, Antonarakis ES, George DJ, Halabi S.
    JCO Precis Oncol; 2020 Jun 01; 4():. PubMed ID: 33154984
    [Abstract] [Full Text] [Related]

  • 10. The Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer Treated With Novel Hormonal Therapy or Chemotherapy: A Systematic Review and Meta-analysis.
    Wang Z, Shen H, Ma N, Li Q, Mao Y, Wang C, Xie L.
    Front Oncol; 2020 Jun 01; 10():572590. PubMed ID: 33425724
    [Abstract] [Full Text] [Related]

  • 11. The association between androgen receptor splice variant 7 status and prognosis of metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.
    Zhou J, Liu R.
    Andrologia; 2020 Aug 01; 52(7):e13642. PubMed ID: 32401357
    [Abstract] [Full Text] [Related]

  • 12. Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients.
    Maillet D, Allioli N, Peron J, Plesa A, Decaussin-Petrucci M, Tartas S, Ruffion A, Crouzet S, Rimokh R, Gillet PG, Freyer G, Vlaeminck-Guillem V.
    Eur Urol Oncol; 2021 Aug 01; 4(4):609-617. PubMed ID: 31676281
    [Abstract] [Full Text] [Related]

  • 13. Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer.
    Qu F, Xie W, Nakabayashi M, Zhang H, Jeong SH, Wang X, Komura K, Sweeney CJ, Sartor O, Lee GM, Kantoff PW.
    Clin Cancer Res; 2017 Feb 01; 23(3):726-734. PubMed ID: 27489290
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial.
    Shenderov E, Boudadi K, Fu W, Wang H, Sullivan R, Jordan A, Dowling D, Harb R, Schonhoft J, Jendrisak A, Carducci MA, Eisenberger MA, Eshleman JR, Luo J, Drake CG, Pardoll DM, Antonarakis ES.
    Prostate; 2021 May 01; 81(6):326-338. PubMed ID: 33636027
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone Acetate.
    Todenhöfer T, Azad A, Stewart C, Gao J, Eigl BJ, Gleave ME, Joshua AM, Black PC, Chi KN.
    J Urol; 2017 Jan 01; 197(1):135-142. PubMed ID: 27436429
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.